SynthesisFrontiers in pediatrics2022

Efficacy and Safety of Omalizumab for the Treatment of Severe or Poorly Controlled Allergic Diseases in Children: A Systematic Review and Meta-Analysis.

Ling Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.